Literature DB >> 11790653

Assessment of a medication-based asthma index for population research.

Wendy J Ungar1, Kenneth R Chapman, Maria T Santos.   

Abstract

Asthma management guidelines recommend the use of preventive medications in sufficient amounts to control asthma symptoms. The validity of a medication use index as a proxy for asthma severity has not been established. We recruited 1,279 Ontario adults with asthma or parents of children with asthma from a community-based surveillance program in 1995-96. Participants completed a telephone questionnaire at baseline, 3 and 6 mo. The questionnaire gathered information about asthma medication use, health care utilization, and symptoms. Asthma was classified as mild in 28%, moderate in 49%, or severe in 23% of patients based on the amount and types of medication used. There were significant differences among groups in health resource use such that adults with higher medication use visited primary care physicians and specialists more frequently, had pulmonary functions tests more frequently, and were admitted to hospital more frequently. The findings among children were similar. There were weak positive correlations between medication use and symptom frequency in adults and children. We conclude that a medication use index may be useful in population-based research where clinical asthma severity data are lacking. Such an index is distinct from but is related to disease control.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11790653     DOI: 10.1164/ajrccm.165.2.2102012

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  11 in total

1.  Toll-like receptor expression on peripheral blood mononuclear cells in asthmatics; implications for asthma management.

Authors:  Eunyoung Chun; So-Hee Lee; Soo-Yeon Lee; Eun-Jin Shim; Sang-Heon Cho; Kyung-Up Min; You-Young Kim; Heung-Woo Park
Journal:  J Clin Immunol       Date:  2010-01-14       Impact factor: 8.317

2.  Risk factors and clinical outcomes associated with fixed airflow obstruction in older adults with asthma.

Authors:  Gregory H Bennett; Laurie Carpenter; Wei Hao; Peter Song; Joel Steinberg; Alan P Baptist
Journal:  Ann Allergy Asthma Immunol       Date:  2017-12-28       Impact factor: 6.347

3.  Dexamethasone-induced FKBP51 expression in peripheral blood mononuclear cells could play a role in predicting the response of asthmatics to treatment with corticosteroids.

Authors:  Eunyoung Chun; Hyun-Seung Lee; Bo-Ram Bang; Tae-Wan Kim; So-Hee Lee; Ju-Han Kim; Sang-Heon Cho; Kyung-Up Min; You-Young Kim; Heung-Woo Park
Journal:  J Clin Immunol       Date:  2010-09-18       Impact factor: 8.317

4.  Development and validation of database indexes of asthma severity and control.

Authors:  Faranak Firoozi; Catherine Lemière; Marie-France Beauchesne; Amélie Forget; Lucie Blais
Journal:  Thorax       Date:  2007-02-07       Impact factor: 9.139

5.  Asthma control score based on filled medication prescriptions: a validation study.

Authors:  Marie-France Beauchesne; Amélie Chartier; Anne Fillion; Catherine Lemière; Sophie Lecompte; Lucie Blais
Journal:  Can Respir J       Date:  2008 Nov-Dec       Impact factor: 2.409

6.  Serum Adiponectin is Associated with Adverse Outcomes of Asthma in Men but Not in Women.

Authors:  Akshay Sood; Elizabeth Dominic; Clifford Qualls; Michael W Steffes; Bharat Thyagarajan; Lewis J Smith; Cora E Lewis; David R Jacobs
Journal:  Front Pharmacol       Date:  2011-10-05       Impact factor: 5.810

7.  Progress in pediatric asthma surveillance I: the application of health care use data in Alameda County, California.

Authors:  Eric M Roberts; Paul B English; Stephen K Van den Eeden; G Thomas Ray
Journal:  Prev Chronic Dis       Date:  2006-06-15       Impact factor: 2.830

8.  Asthma during pregnancy in a population-based study--pregnancy complications and adverse perinatal outcomes.

Authors:  Gustaf Rejnö; Cecilia Lundholm; Tong Gong; Kjell Larsson; Sissel Saltvedt; Catarina Almqvist
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

9.  Expression of semaphorin 3A and neuropilin 1 in asthma.

Authors:  Eun-Jin Shim; Eunyoung Chun; Hae-Ryun Kang; Sang-Heon Cho; Kyung-Up Min; Heung-Woo Park
Journal:  J Korean Med Sci       Date:  2013-09-25       Impact factor: 2.153

10.  A polymorphism in the histone deacetylase 1 gene is associated with the response to corticosteroids in asthmatics.

Authors:  Min-Hye Kim; Sae-Hoon Kim; Yook-Keun Kim; Soo-Jong Hong; Kyung-Up Min; Sang-Heon Cho; Heung-Woo Park
Journal:  Korean J Intern Med       Date:  2013-10-29       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.